Health Wildcatters is a mentor-driven seed accelerator focused on improving healthcare by supporting entrepreneurs and healthcare startups. Healthcare IT, SaaS, digital health and mobile health companies are a fit, but they also encourage medical device, diagnostic and pharmaceutical companies to apply. What They Look For: Technology: Digital Health, mHealth, HealthIT, Medical Devices, Pharma, Diagnostics Customers: Hospitals, patients, doctors, anyone who could conceivably be a healthcare consumer Location: Any company founders who will live in Dallas for the program Founders: Well-rounded founder teams >1 person, demonstrated understanding of entrepreneurship, relevant technical and business knowledge Capital: Needing seed capital to support living expenses while bootstrapping, can make efficient use of limited capital, would generally be planning on self/angel/customer financing as a next step coming out of the program.
Acute XR develops innovative virtual reality therapy games aimed at enhancing mental health. The company's offerings immerse users in captivating digital environments that promote relaxation and well-being. By integrating therapeutic practices with engaging gameplay, Acute XR enables medical professionals to deliver effective treatment in a manner that is both enjoyable and motivating for patients.
Rhythmm AI is transforming healthcare administration with its AI-powered prior permission software, which intelligently automates tedious paperwork, research, and approvals.
TSP Therapeutics
Pre Seed Round in 2024
TSP Therapeutics is a registration-stage oncology firm developing and commercializing histamine signaling therapeutics to be used in conjunction with immunotherapies to help save the lives of cancer patients who are resistant to immunotherapy.
TeachMeNow is an AI-powered digital health product that transforms how patients understand their medical data. It focuses on serious issues in the healthcare industry, such as high readmission rates, rising expenditures, and the widespread problem of health illiteracy.
MucoLife Therapeutics is transforming the therapeutic landscape for Chronic Obstructive Pulmonary Disorder (COPD) by creating first-in-class mucolytic medicines that target mucus congestion in the airways.
SensArs is a medical equipment manufacturing company specializing in neuromodulation technology aimed at treating diabetic neuropathy. The company has developed an innovative implantable neurostimulator electrode designed to restore sensory feedback by delivering precise electrical impulses to the nerve fibers that transmit pain signals. This technology not only assists healthcare providers in enhancing patient functionality but also offers a long-term solution for pain management. SensArs' flagship system, SENSY, is particularly beneficial for patients with amputations or nerve damage, as it helps to restore natural sensations in their feet.
Keyron is a preclinical-stage medical device and technology platform company dedicated to treating metabolic diseases, particularly type 2 diabetes, non-alcoholic steatohepatitis (NASH), and obesity. The company has developed a patented medical device called ForePass, which has demonstrated the ability to safely reverse insulin resistance in animal studies, with findings published in The Lancet EBioMedicine. Keyron's innovative approach includes endoscopically implantable devices that replicate the surgical procedures associated with sleeve gastrectomy and gastric bypass, allowing for a minimally invasive treatment option that combines the safety of such devices with the effectiveness of bariatric surgery. Keyron plans to initiate clinical trials in South America before expanding to the United States.
Mind+ focuses on Latina women experiencing high-risk pregnancies. The company hopes to enhance outcomes by utilizing telemedicine emotional and behavioral assistance.
WellnessWits is a developer of a digital health platform focused on addressing chronic health issues while reducing hospitalizations and frequent doctor visits. The company provides digital therapeutic solutions to primary care providers, specialists, and coaches, facilitating automated care delivery. Its platform enables clinicians to digitize, standardize, and automate the management of care for patients with chronic conditions through an end-to-end open system for virtual shared medical appointments. This approach enhances the efficiency of care delivery and supports better health outcomes for patients.
Nexterra Medical's mission is to create clean technology that eliminates the possibility of unintentional needle injuries and liability, resulting in a safer world.
OncoSwab is creating a point-of-care test to detect lung cancer in high-risk individuals. The goal is to make screening more accessible to people in order to enhance lung cancer detection.
MedKitDoc operates a remote medical care platform that facilitates consultations and treatments via video calls and connected medical devices. This innovative approach allows patients to receive care for 48 out of the 50 most common chronic diseases, significantly enhancing the scope of remote healthcare compared to traditional video-only consultations, which address only 24 conditions. By enabling real-time transfer of health data, MedKitDoc aims to reduce unnecessary hospitalizations by up to 50 percent. The platform is designed to improve the quality of life for chronically ill patients, and the company collaborates with various healthcare providers to deliver effective remote medical services.
D&P Bioinnovations is a medical device company that specializes in developing implantable and bioresorbable technologies aimed at regenerating damaged organs, particularly the esophagus. Their innovative device utilizes unique biomaterials and immunomodulatory stem cell factors, making it suitable for treating esophageal cancer and addressing conditions such as long gap esophageal atresia and caustic ingestion in pediatric patients. The technology has been rigorously tested in six different diseased animal models and has the potential to extend beyond esophageal applications to assist in the regeneration of blood vessels, nerves, muscles, tendons, ligaments, and gastrointestinal ulcers.
Beam Wellness is a sort of low-level light therapy that enhances skin health and appearance through red light therapy. Applications include faster healing, cleaner skin, and fewer symptoms of aging.
OUI Medical Inc. is a medical device company founded in 2021, focused on transforming the examination of the abdominal cavity. The company specializes in the development and distribution of innovative medical devices, with its flagship product, the P-Scope, designed for non-invasive and cost-effective procedures. This single-use device allows for examinations under local anesthesia in outpatient settings, providing a less invasive alternative to traditional methods such as laparoscopy and laparotomy. OUI Medical targets secondary and tertiary hospitals globally, catering to various medical specialties including gastroenterology, oncology, gynecology, and emergency care. The company plans to partner with large original equipment manufacturers for marketing and distribution to accelerate market penetration and establish the P-Scope as a standard diagnostic tool. Initially funded through self-investment and support from a med-tech accelerator, OUI Medical aims to raise additional funds for regulatory clearance and market entry in key regions. The company's goal is to sell 500,000 units of the P-Scope at an average price of $2,000 each, projecting revenue of $1 billion within five years while enhancing healthcare outcomes and accessibility.
Aptus. Life provides and bills organizations that want to meet regulations, build their practice, and keep patients in great care. Aptus ensures compliance, enhances the patient experience and maximizes reimbursements by focusing on the strategy to effect positive change.
VenoVision is an AI-driven platform that specializes in contactless cardiopulmonary monitoring, aiming to enhance cardiac care for patients with heart failure and those at risk. By utilizing a thermal imaging monitoring device, VenoVision provides continuous hemodynamic assessments, allowing medical teams to gain insights that were previously only available through invasive cardiac catheterizations. The system is designed to monitor patients post-hospitalization, identifying and alerting healthcare providers to any deterioration in conditions before they escalate, thereby reducing costly admissions to cardiac ICUs. This innovative approach not only improves patient stability at discharge but also facilitates compliance monitoring for various conditions, ultimately contributing to better outcomes for millions of patients.
KIOMA is a company focused on designing and manufacturing innovative baby car seats. Utilizing carbon fiber in its products, KIOMA aims to enhance safety and convenience for parents and their children. The lightweight nature of carbon fiber allows for easy handling, lifting, and cleaning, while its impact-absorbing properties ensure a higher level of protection for infants during travel. By prioritizing both functionality and safety, KIOMA seeks to transform the travel experience for families with young children.
QuantiFace
Seed Round in 2022
AI-Based consultation App for Aesthetic Practitioners
A LaRue Company is a business that plans to create, develop, and sell medical equipment. Founded in 2019 and is based in Winston Salem, North Carolina, United States.
Aliform is a medical device startup focused on enhancing the safety, ease, and accessibility of skin surgery for patients and clinicians. The company has developed an innovative surgical tool known as Celluleaf, which facilitates the treatment of skin connective tissue defects through minimally invasive techniques. This device is designed to perform blunt dissection, allowing physicians to address conditions such as cellulite, scars, and skin grafting while minimizing damage to surrounding tissue structures. Aliform collaborates closely with clinicians to ensure that its products meet the needs of medical professionals and improve patient outcomes.
Sovrinti is a developer of home sensing systems focused on identifying behavior patterns that may indicate significant health conditions. The company utilizes a suite of smart home sensors that do not rely on video or audio, allowing for discreet monitoring. This technology gathers real-time location data to establish personalized baseline behavior patterns. By doing so, Sovrinti aims to facilitate earlier clinical diagnosis and treatment for aging individuals, promote person-centered home care, and ultimately improve health outcomes while reducing costs. Through its innovative approach, Sovrinti addresses the growing need for effective health monitoring solutions within the home environment.
Oral Genome is a health and wellness company focused on transforming oral care by identifying potential health issues. The company provides a dental testing kit that offers individuals insights into their oral health by measuring the microbiome and biomarkers associated with the risk of cavities and other diseases. This innovative approach enables patients to receive tailored recommendations for their oral health, allowing them to take preventive measures against dental issues. Through its offerings, Oral Genome aims to enhance oral care and contribute to overall health and wellness.
Parrots Inc. is a medical devices company focused on developing assistive technology for individuals with mobility and communication challenges. Their flagship product, Polly, serves as a socially assistive robot that enables users to interact more effectively with their environment. Polly operates as a hands-free device, using eye-tracking and other switches for control, allowing for seamless communication. The platform incorporates advanced artificial intelligence and machine learning to facilitate real-time communication, significantly enhancing the speed and efficiency of interactions compared to traditional devices. Parrots emphasizes five core values: communication, control, connectivity, compatibility, and caregiving. These principles guide the development of products that maximize user independence while also supporting caregivers by reducing their workload. The technology not only assists in communication but also tracks vital signs and health metrics, providing comprehensive support for users with neurological disorders and physical disabilities.
Sympal is a clear aligner company focused on enhancing orthodontic care by offering safer, more effective, and affordable solutions for teeth straightening. Unlike competitors, Sympal requires orthodontic clearance from a dentist and employs a real-time treatment tracking system monitored by a doctor, ensuring comprehensive care. The company's innovative design addresses the root causes of crooked teeth rather than merely alleviating symptoms, allowing it to manage a wider range of cases. Sympal's aligners are priced at half the cost of traditional options, making quality orthodontic treatment accessible to more patients. Founded by experienced dental entrepreneurs, Sympal's team includes skilled dentists, orthodontists, and engineers dedicated to streamlining the teeth straightening process for better patient outcomes.
AllergenIQ is a provider of virtual allergy care services focused on delivering effective allergy relief. The company aims to improve healthcare outcomes and enhance access to expert care through its online consultations. By emphasizing management strategies for chronic allergic conditions, particularly food allergies, AllergenIQ enables customers to address their allergy concerns from the comfort of their homes.
Health Haven Rx is building the future of digital pharmacy services. We are on a mission to make pharmacy services more affordable while delivering quality care
ColonAI is a medical device company focused on enhancing colorectal cancer screening and treatment. The company has developed an artificial intelligence-enabled platform that assists physicians in detecting and removing colorectal tumors. Its software is designed to identify missed polyps and those that have not been completely removed, as well as to detect lesions in the small bowel. By optimizing the workflow of healthcare professionals, ColonAI aims to improve patient outcomes and reduce mortality associated with colorectal cancer.
Iluria is a digital health company focused on supporting caregivers and families in the management and treatment of attention-deficit hyperactivity disorder (ADHD). Founded in 2018 and based in Hod Hasharon, Israel, Iluria employs a machine learning and deep learning-based platform to enhance the traditional trial-and-error treatment process for ADHD patients. The company's solution includes a comprehensive software as a service (SaaS) offering that provides continuous and passive monitoring through the use of biomarker data from various smart wearables. This system delivers personalized and objective real-time insights to healthcare providers via a professional web application and to parents through a mobile app, aiming to improve treatment decisions for those affected by ADHD.
Loop Dx is developing point-of-care diagnostics for faster detection of sepsis to reduce sepsis mortality, patient side effects, and antibiotic resistance due to unnecessary provided antibiotics. We want to facilitate healthcare providers the tools they need for faster sepsis identification saving lives and optimizing sepsis management.
Spectrum Disinfection is a company based in Denver, Colorado, that specializes in developing a patented process to stabilize chlorine dioxide, a powerful industrial disinfectant known for its effectiveness against pathogens. Founded in 2018, the company aims to provide a liquid surface disinfectant that not only ensures high performance in preventing disease transmission but also mitigates the environmental drawbacks associated with traditional disinfectants. By focusing on this innovative approach, Spectrum Disinfection is poised to introduce its first products to the market and is currently seeking seed investors to support this launch.
Developer of a Web-based enterprise platform designed to empower life scientists with time and cost saving software for their high-quality product development workflow. The company's platform offers scientific and technological support to streamline workflow in areas as diverse as customer needs in agricultural biotechnology and helps scientists spend more time on answering biological questions, enabling biologists to efficiently manage, quickly analyze and easily visualize microbial genome sequence data.
Developer of an online healthcare data analysis platform designed to decrease hospital and medical costs while increasing healthcare efficiency. The company's platform utilizes artificial intelligence to implement clinical decision support systems, and computer-based programs that analyze healthcare data and predict medical needs, enabling healthcare providers to increase labor efficiency by implementing a clinical decision support system, thus improving patient outcomes.
Noleus Technologies Inc., based in Houston, Texas, is focused on developing a medical device that enhances patient recovery after abdominal surgery. Their product aims to prevent postoperative ileus and intestinal wall edema, which are common complications that can extend patients' hospital stays and increase healthcare costs. By addressing these issues, Noleus's device facilitates a quicker return of bowel function, leading to fewer complications and enabling patients to be discharged earlier. This approach not only benefits patients by promoting faster recovery but also saves time for physicians and reduces costs for hospitals, addressing an important gap in current medical solutions for abdominal surgery recovery.
Halo Health Systems is a healthcare company dedicated to enhancing patient care through innovative technology. It specializes in patient-centric clinical trials aimed at reducing the burden on patients and healthcare facilities. The company has developed a medical-grade wearable device that is designed to be worn on the upper arm. This tool continuously monitors vital signs, including blood pressure, respiratory rate, heart rate, mobility, oxygen saturation, temperature, and perspiration. By providing real-time data, the device enables healthcare providers to identify patients at high risk of acute health deterioration, both in hospital settings and at home, thereby improving patient outcomes and fostering timely interventions.
OneSeventeen Media, Inc. is a company focused on developing social media tools aimed at promoting the well-being of children aged 10 to 14. Based in Austin, Texas, the company offers a range of services, including MyMobileMentor, a digital first responder that equips kids with essential skills to navigate challenging situations during their teenage years. Additionally, OneSeventeen Media has created reThinkIt!, a telebehavioral mental health platform that utilizes live chat and chatbot assistants to help children process difficult emotions and understand their behaviors. The company also provides an integrated real-time behavior management system for schools, supporting both parents and educational institutions in addressing complex issues related to children's social-emotional health with evidence-based and personalized content. Since its incorporation in 2008, OneSeventeen Media has aimed to empower young individuals to make informed decisions in various environments, including school and home.
Perinatal Access is a digital health company focused on enhancing perinatal care for pregnant individuals and their families. The company has developed a telemedicine platform that enables users to connect with specialists through video chat and live ultrasound streaming, ensuring access to essential care regardless of geographical location. This innovative approach aims to provide convenient and accessible healthcare services, thereby alleviating the stress and anxiety often associated with traveling for medical appointments. By leveraging technology, Perinatal Access addresses the unique needs of pregnant individuals, facilitating timely consultations and expert guidance during critical stages of pregnancy.
Aurie is a medical device company based in New York, established in 2018. It focuses on developing a reusable urinary catheterization system aimed at improving the quality of life for individuals with disabilities. By providing a convenient, discreet, and hygienic catheterization option, Aurie seeks to reduce the risk of infections and enhance users' confidence and control over their healthcare needs. The company's innovative approach empowers users to manage their condition more effectively, enabling them to lead active and fulfilling lives.
Health Haven Rx is building the future of digital pharmacy services. We are on a mission to make pharmacy services more affordable while delivering quality care
VasoGnosis is an AI-powered diagnostic and surgical planning software platform focused on cerebrovascular diseases, particularly brain aneurysms. Founded in 2019 and headquartered in Milwaukee, Wisconsin, the company develops a computed-assisted diagnostic tool that automates the analysis of brain aneurysms. This tool offers advanced visualization and analysis of an individual's vascular anatomy in the affected region, supporting neurosurgeons and interventional neuroradiologists in making informed decisions that enhance patient outcomes. By leveraging machine learning, VasoGnosis aims to improve the quality of care for patients with complex vascular conditions.
At Vitrix Health, we created a more accessible oral health screening solution. We use optics paired with machine learning on a mobile platform to enable medical primary care providers (PCP) to screen for oral diseases more effectively. Given the link between oral and systemic health, this improves outcomes and costs for the 108M Americans that don’t see a dentist but do see a doctor every year and other high-risk groups.[1] Our technology reduces disparities in oral health by empowering the PCP to detect disease and intelligently refer the right patients to a dentist. Our device is pilot testing in Mt. Sinai Hospital in New York, Carle Clinic in Illinois, and University Of Chicago Medical School in Illinois. We also have 2 international clinical trials with the Rotary Foundation in Bolivia and Manipal College of Dentistry in India.
Stingray Therapeutics is a biotech company based in Houston, Texas, founded in 2018. The company specializes in developing innovative immunotherapies aimed at treating various forms of cancer. Its approach includes the creation of oral medications that stimulate innate immunity modulators within interferon gene pathways. These therapies feature potent and selective small molecule inhibitors designed to enhance the immune system's ability to combat cancer effectively. By integrating these mechanisms, Stingray Therapeutics aims to provide clinicians with advanced tools to improve cancer treatment outcomes.
Runnur is a developer of Sentiv, a fitness incentive app that provides its users with the causefit platform helping them to reach their fitness goals. It was founded in May 2016.
MycoDART Inc., is the developer of molecular diagnostic tests for the rapid detection of deadly infections in very vulnerable patients such as transplant, cancer, and AIDS. Their team has dozens of years experience in business management, laboratory operations, and molecular diagnostics development. They are in the pre-launch stage for MycoDART-PCR Candida Panel. This test will identify Invasive Candidiasis infections earlier and with higher reliability than the current standard of care. As such, it will reduce mortality and cost of treatment for thousands of patients. A panel for Invasive Aspergillosis will follow.
ClikRx is a digital health company that provides a prescription processing platform designed to streamline the integration of local providers into hospital medical record systems. By connecting healthcare providers with hospitals, ClikRx facilitates a network that allows doctors to efficiently route patients based on their insurance and required services. The platform enables physicians to manage all referral paperwork in one place, enhancing the efficiency of the referral process while maintaining patient data security. This approach simplifies the prescribing of durable medical equipment and other services, ultimately improving the overall workflow for healthcare professionals.
VenoStent, Inc. is a clinical-stage tissue engineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Founded in 2017, it specializes in the development of bioresorbable smart polymers designed to enhance vascular surgery outcomes. The company’s primary product, SelfWrap, is a perivascular wrap that functions as an external stent, providing mechanical support to veins and promoting outward growth. This innovative technology aims to reduce complications at the vein-artery junction in dialysis patients, particularly by minimizing vein collapse and improving the usability of arteriovenous fistulas (AVF). By utilizing a new class of shape-memory polymers that do not require sutures, VenoStent's approach reduces surgery time and lowers the risk of infection, ultimately enhancing the quality and length of life for patients with chronic kidney disease undergoing hemodialysis.
Benefizz, LLC is a producer of all-natural, effervescent probiotic beverages, including a water kefir drink flavored with an organic mixture of lemons, figs, and other fruits. Established in 2015 and based in Memphis, Tennessee, Benefizz aims to provide a healthy alternative to traditional soft drinks, with each bottle containing less than five grams of sugar. The company's products are distributed through food retailers and restaurants across Tennessee, offering consumers a range of naturally fizzy drinks that prioritize both taste and health benefits.
Ataia Medical, founded in 2017 by biomedical engineers and critical care physicians, focuses on enhancing communication for hospital patients who are unable to speak due to the constraints of hard plastic masks. The company has developed an innovative medical device and communication system that serves as an intuitive aid, establishing channels for patients to connect verbally with their physicians, caregivers, and family members. This system is particularly beneficial for patients undergoing non-invasive ventilation and oxygen therapies in critical care settings, allowing them to express their needs and concerns effectively. Through these solutions, Ataia Medical aims to empower patients with the ability to communicate during critical moments of care.
Gregor Diagnostics Inc. is a molecular diagnostics company based in Madison, Wisconsin, founded in 2016. The company focuses on developing innovative screening tests for prostate cancer, utilizing seminal fluid as a sample source. Its technology aims to detect prostate cancer at early stages and differentiate between indolent and aggressive forms of the disease. This capability enables physicians to minimize overdiagnosis and overtreatment of less aggressive cancer while enhancing the detection and management of more aggressive cases. Gregor Diagnostics' approach represents a significant advancement in the field of prostate cancer diagnostics.
Nobo, Inc. is a company based in Milwaukee, Wisconsin, that specializes in developing a connected wearable device to monitor the hydration levels of elite athletes. Utilizing patent-pending, non-invasive optical technology, the device employs near-infrared light to illuminate specific areas of the body and measure the reflected light. This process provides real-time insights into the body's total water content and other important biometrics. Nobo's innovative approach aims to enhance the understanding of hydration for athletes, trainers, clinicians, and health-conscious consumers, as well as individuals in demanding work environments and hospital patients.
Articulate Labs, Inc. is a medical device company based in Austin, Texas, that specializes in developing wearable technology for the treatment of knee osteoarthritis. Founded in 2009, the company produces KneeStim, a device that employs neuromuscular electrical stimulation (NMES) to enhance muscle function and support rehabilitation during everyday activities. By integrating motion-tracking hardware and clinician input, the device tailors stimulation patterns to align with the user's natural movement, effectively combating muscle atrophy and inhibition associated with chronic conditions or recovery from surgery. Articulate Labs aims to make physical rehabilitation more accessible and effective, allowing patients to engage in their daily routines while receiving therapeutic benefits.
Insight Optics is a startup focused on enhancing preventive healthcare by connecting primary care providers (PCPs) with local specialists for assisted diagnostics. The company has developed a telemedicine platform that allows PCPs to easily record and refer retinal exams to specialists, facilitating early detection of diseases such as retinopathy and glaucoma, particularly in patients with diabetes and hypertension. Insight Optics aims to address the challenge faced by over 154 million patients in the United States who are recommended for annual retinal exams but often do not receive them due to barriers such as accessibility and education. By leveraging mobile imaging technology and machine learning, the platform ensures that the captured content is of diagnosable quality before transmission. This innovative solution not only helps PCPs create new revenue streams through reimbursements and government incentives but also improves patient care by increasing screening capacity, particularly for marginalized and rural populations. Overall, Insight Optics is committed to making preventive healthcare more accessible and effective.
Provider of a health system to connect providers with clients. The company's application offers behavioral health system allows providers to access critical data that can be used to improve treatment and outcomes engagement.
MediBookr is a patient engagement and navigation platform that enhances the healthcare experience by providing innovative tools for patients, health plans, and providers. The platform allows users to search for and book appointments at rated imaging centers, offering transparent price quotes and options tailored to individual needs. MediBookr's technology facilitates seamless communication between patients and health providers, enabling efficient access to virtual care. By emphasizing flexible and adaptive engagement, the platform aims to reduce healthcare costs and improve health outcomes. Additionally, MediBookr offers consulting, hosting, and advocacy services to further support its users in navigating the complexities of healthcare.
Optonome is a healthcare technology company that focuses on enhancing the efficiency of home and community care providers, particularly for individuals with disabilities and seniors who prefer to age in place. The company offers a unique model that creates a network of boutique home health care agencies owned and operated by nurses and therapists, ensuring high-quality care at lower costs. This network comprises over 150 clinician-owned agencies across the United States, which provide community-based support to help individuals lead more independent and meaningful lives. Optonome's application serves as a care coordination system that connects clinicians, families, and support professionals, and includes educational resources to streamline care delivery. The company aims to generate significant social impact, with projections indicating over $330 million in benefits over the next three years, including increased earnings for care workers and improved access to affordable housing for vulnerable populations. Overall, Optonome's innovative approach offers considerable advantages over traditional healthcare models.
HealPal Inc. operates an online platform designed for cancer patients and their families, helping them to navigate the complexities of cancer treatment and care. The platform offers a community where users can learn about various treatment options, including chemotherapy, immunotherapy, and targeted therapy, while connecting with others facing similar challenges. HealPal provides accessible information through easy-to-understand infographics and videos, enabling patients to engage with healthcare professionals regarding medication advice, clinical trials, and treatment schedules. By fostering connections among patients and offering valuable insights into the latest discoveries in cancer care, HealPal aims to improve outcomes for those affected by cancer. The company is headquartered in Sunnyvale, California.
ClinicalSolutions.io is an online platform designed to connect individuals seeking clinical trials with medical researchers. By creating a medical profile, users can easily find and apply for clinical trials that match their specific conditions. The platform aims to streamline the process of connecting clinical trial volunteers with researchers, enhancing efficiency and security. With a vision to eliminate orphan diseases by 2050, ClinicalSolutions.io is committed to facilitating meaningful connections in the medical research community.
Sentinel Diagnostic Imaging, Inc. is a medical image analysis company that provides innovative software to improve the precision and early detection of sight-threatening retinal vascular diseases. The Oqulus analysis system computes quantitative objective metrics characterizing the structure and health of the retinal vasculature from standard digital photographic images of the retina.
Nutrition has been overly simplified to just counting calories. InRFood delivers a true personalized "health and wellness" solution through a mobile app to interpret nutrition beyond calories. Since each person has unique nutritional needs, InRFood uniquely takes into account dietary concerns, along with logging ingredients and macro nutrients in order to come up with an impactful personalized experience. The analysis of your nutrition can then be connected to professionals for additional assessment.
Exhale Advisors was founded in 2017 with a single mission: to massively improve the access, quality and cost of the US healthcare system. We approach each of our clients with fresh eyes and develop strategies that will accelerate your growth.
Flow MedTech is a medical device company focused on addressing the needs of cardiovascular physicians in the operating room. The company has developed a medical stimulation device aimed at preventing strokes in patients with irregular heartbeat rhythms, particularly those suffering from atrial fibrillation. This device works by reducing the risk of clot formation in the left atrial appendage, thereby enabling healthcare providers to deliver more effective treatments and facilitate quicker recovery for patients with cardiac disorders.
Dynofit, Inc. specializes in developing applications and software that integrate sensors with mobile technologies to enhance physical therapy practices. Founded in 2012 and based in Los Alamos, New Mexico, the company focuses on making therapies accessible outside traditional clinical settings, particularly for individuals with neuro-muscular impairments caused by conditions such as stroke, cerebral palsy, and spinal cord injuries. One of its key offerings is a mobile application and clinical dashboard known as DOTs, which facilitates EMG biofeedback rehabilitation. This system not only digitizes and stores therapy data but also increases patient engagement and provides therapists with valuable information about patient progress between visits. By leveraging innovative technology, Dynofit aims to significantly improve the quality of life for its users.
md Portal is a telemedicine platform designed for dermatologists and other medical specialists, aimed at enhancing patient care through online visits. The platform streamlines the process of delivering high-quality follow-up care and allows healthcare providers to treat new patients without interrupting their clinic workflows. By utilizing questionnaires and photo submissions, md Portal facilitates efficient online consultations. Additionally, the platform offers cloud-based services, including website and payment integration, while ensuring HIPAA-compliant security. This technology enables both patients and physicians to benefit from a user-friendly experience that promotes practice growth and improves access to healthcare services.
DUALAMS is a medical device developer whose goal is to make patients' pre-and post-operative experiences as painless as possible. The company's medical device allows professionals to inject nebulized lidocaine, which speeds up the process and reduces reflex gagging, coughing, aspiration, bucking, and laryngospasm, managing to complete examinations relatively quickly. They are a medical device startup with two pending patents, the first of which ultrasonically nebulizes local anesthetics and directs them to specific delivery points in the vocal anatomy. The second invention uses ultrasound to nebulize medical substances and direct them to specific bodily regions that are accessible via flexible endoscopes.
Noninvasix, Inc. is a medical technology company based in Galveston, Texas, that specializes in non-invasive precision oximetry for measuring brain oxygenation in preterm infants within neonatal intensive care units. Founded in 2007 by Dr. Donald Prough and Dr. Rinat Esenaliev at the University of Texas Medical Branch, the company has developed a novel optoacoustic platform technology that allows for continuous monitoring of oxygen sufficiency in organs and veins without the need for invasive procedures. This technology is particularly useful in diagnosing and managing conditions such as sepsis and septic shock, enabling clinicians to assess tissue hypoxia in real-time and adjust treatments accordingly. Noninvasix has received over $6.8 million in funding, including substantial grants from the NIH and DOD, and has been recognized in various prestigious accelerator programs. The company's innovations have been validated in multiple peer-reviewed studies, and its intellectual property includes numerous patents both in the U.S. and internationally.
Cloud 9 is on a mission to disrupt massive waste and mistreatment of people with mental illness. Cloud 9’s proprietary patient-centric technology platform allows multidisciplinary care teams (including mental healthcare, primary care, substance use specialists and first responders) to communicate and share data with one another and their patients. They keep high risk patient populations engaged in treatment to keep them out of crisis, before they land in ERs, jails, courts or the streets. Their technology and service model innovation deliver a paradigm shift that can save billions for state and local budgets, while also helping underserved individuals. The larger social impact is that healthy minds create healthier communities, workplaces, homes, and future generations.
Sintact Medical Systems, Inc. is engaged in the development of non-resorbable films that prevent adjacent organs from adhering to each other following surgical procedures. These films serve as a barrier against scar formation, significantly reducing the risk of surgical adhesions and related post-operative complications. Founded in 2013 and headquartered in Bloomington, Indiana, the company aims to enhance patient outcomes by providing a clear plane of dissection for potential future surgeries, thereby facilitating easier re-operation if necessary.
Orb Health, Inc. is a mobile healthcare technology company based in Richardson, Texas, founded in 2011. It specializes in providing innovative solutions that facilitate access to personalized healthcare services for physicians, employers, clinical laboratories, and patients. The company’s flagship offering, Collaborative Virtual Care, allows healthcare providers to deliver reimbursed Medicare services, including Chronic Care Management, as a virtual extension of their practice. This model eliminates the need for additional staff, applications, or office space, integrating seamlessly with existing electronic medical records (EMR) systems. By embedding best practices into its workflow, Orb Health empowers remote providers to deliver high-quality care while enhancing collaboration among healthcare teams. This approach not only improves patient access and outcomes but also increases reimbursements and overall profitability for various healthcare organizations, including Federally Qualified Health Centers and Accountable Care Organizations.
Nutrition has been overly simplified to just counting calories. InRFood delivers a true personalized "health and wellness" solution through a mobile app to interpret nutrition beyond calories. Since each person has unique nutritional needs, InRFood uniquely takes into account dietary concerns, along with logging ingredients and macro nutrients in order to come up with an impactful personalized experience. The analysis of your nutrition can then be connected to professionals for additional assessment.
Silicone Arts Laboratories, LLC develops and markets products that enhance physical appearances. It provides AeXP (Anatomical Eye – Experimental), a precise replica of a human eye developed for medical training and medical device testing market; and Dermaflage, a topical scar filler that provides a cosmetic option for concealing recessed scars and skin defects on the face and body without surgery and injections. The company was founded in 2010 and is based in Memphis, Tennessee.
Carevature Medical Ltd. is a privately held medical device company based in Rehovot, Israel, established in 2011. The company specializes in developing innovative tools and procedures for orthopedic surgeries, primarily focusing on spinal surgery and joint arthroscopy. Carevature Medical has created a proprietary device platform that enables direct decompression through an indirect approach, which helps preserve healthy tissue, reduce trauma, and lower both surgical time and costs. The product line includes disposable items for open and mini-open spinal decompressions, as well as devices for various lumbar and cervical spine procedures, such as foraminotomy, laminotomy, and osteophyte removals. The company continues to explore advancements in its technology for both spine and joint applications.
Platform has changed the way industrial manufacturing and customization come together. Using 3D scanning technologies and propitiatory modeling and optimization software, our product enables digital manufacturing of better fitting custom orthotics. The technology allows precise modification of the 3D scanned models according to morphological and spectral information as well as precise control over the material properties. Platform's technology enables the creation of custom flip-ons, sandals and sportswear as well as clinical orthotics for high risk feet patients and diabetic ulceration patients.
BreathalEyes, Inc. is a technology company based in Winnsboro, Texas, that has developed a mobile application designed to measure an individual's blood alcohol content (BAC) using a method known as Horizontal Gaze Nystagmus (HGN). This innovative app tests intoxication levels by tracking involuntary fluctuations in the pupil as the eye gazes at a fixed point to the side of the face. The application offers a reliable and non-invasive way to assess BAC in real-time, aiming to promote safety by helping users make informed decisions about their sobriety. By providing an instant and cost-effective means to evaluate intoxication, BreathalEyes addresses a critical need in the market, potentially reducing the incidence of accidents and fatalities associated with drunk driving.
Lantern Pharma Inc. is a clinical stage biotechnology company based in Dallas, Texas, specializing in precision oncology therapeutics. The company employs artificial intelligence and machine learning to develop innovative cancer treatments and to revitalize abandoned drug candidates. Its lead drug candidate, LP-100, is currently undergoing phase II clinical trials for metastatic, castration-resistant prostate cancer. Additionally, Lantern is developing LP-300 as a combination therapy for female non-smokers diagnosed with non-small cell lung cancer adenocarcinoma. The firm is also advancing LP-184, a preclinical drug candidate designed to target cancer cells that overexpress specific biomarkers. Lantern Pharma utilizes its proprietary RADR platform to address challenges in oncology drug development, such as patient stratification and understanding mechanisms of action, thereby aiming to accelerate the development of personalized cancer therapies.
GetFittter Inc. provides a comprehensive digital platform that connects fitness enthusiasts with professional health coaches through its mobile and web application. The service allows users to subscribe to digital coaching from a curated selection of renowned trainers, offering personalized health programs tailored to individual goals. The application features tools for personal trainers to manage workouts and monitor client progress, while clients can access workout plans, track their training sessions, and receive feedback. Additionally, GetFittter enhances user engagement by enabling interaction with training equipment through animated sequences and detailed explanations. The platform also supports integration with compatible wearable devices to streamline progress tracking. Headquartered in the United States, GetFittter aims to create new revenue channels for health coaches while fostering a supportive community for users on their fitness journeys.
Cariloop, Inc. offers a digital platform designed to assist seniors and their families in navigating geriatric care options. The platform connects users with a variety of services, including assisted living facilities, Alzheimer care, adult daycare, hospice care, skilled nursing facilities, and home health care. It enables care providers to showcase their services through real-time updates, multimedia content, and analytics on user engagement. Additionally, Cariloop provides a team of experienced Care Coaches who offer personalized guidance to families throughout their caregiving journey. By combining these resources, Cariloop aims to alleviate caregiver stress, enhance collaboration among care teams, and facilitate better care management for seniors. Founded in 2012 and headquartered in Dallas, Texas, Cariloop serves as a comprehensive support system for families facing the complexities of elder care.
ImageVision specializes in providing advanced image and video recognition solutions for social media and multimedia platforms. By utilizing artificial intelligence and machine learning, the company automates the recognition and monetization of visual content, thereby enhancing revenue opportunities and safeguarding brand integrity for its clients. Their real-time visual recognition technology is employed by major industry players to facilitate image search, brand analytics, and ad customization, while also effectively managing objectionable content. ImageVision's platform includes features for automated filtering, motion recognition, and facial biometrics, enabling clients to operate more efficiently and reduce risks associated with content management.
Socrates Health Solutions improves access to affordable care via the application of technology and delivery models. They are currently engaged in Series A activities. Socrates Health Solutions is headquartered in Dallas, Texas, and is a Delaware based corporation.
Nexeon MedSystems is a bioelectronics company focused on developing active medical devices for chronic medical conditions. The company specializes in neuromodulation technology and aims to address disorders associated with nervous system tissues. Nexeon MedSystems integrates various fields, including electronics, software, mechanical engineering, material science, pharmaceuticals, protein chemistry, and cell biology, to create innovative solutions for patient care. Through its technology platform, the company is committed to advancing medical treatment options in the realm of neurostimulation.
CareStarter helps Children’s Hospitals, pediatric-focused health plans, specialty clinics, and federally qualified health centers automate and scale their small care management teams that are getting to less than 1% of patient interactions to reach 100% of their patient population with a 70% adoption rate. Our platform is the first fully automated tool enabling value-based healthcare organizations to de-risk their patient populations using social determinants of health/demographics. It was founded in 2013 and is headquartered in Austin, Texas.
Cariloop, Inc. offers a digital platform designed to assist seniors and their families in navigating geriatric care options. The platform connects users with a variety of services, including assisted living facilities, Alzheimer care, adult daycare, hospice care, skilled nursing facilities, and home health care. It enables care providers to showcase their services through real-time updates, multimedia content, and analytics on user engagement. Additionally, Cariloop provides a team of experienced Care Coaches who offer personalized guidance to families throughout their caregiving journey. By combining these resources, Cariloop aims to alleviate caregiver stress, enhance collaboration among care teams, and facilitate better care management for seniors. Founded in 2012 and headquartered in Dallas, Texas, Cariloop serves as a comprehensive support system for families facing the complexities of elder care.
Make My Plate is changing the dieting world! They present a visually appealing and fun approach to maintaining a healthy lifestyle. They are connecting the dietary ecosystem, answering the user's nutritional needs on one hand and creating a marketplace for professionals on the other.
Remind Technologies LLC is a medical device company headquartered in Houston, Texas, specializing in integrated software and hardware solutions for medication adherence. The company's flagship product, MindRx, is a smartphone-based pill dispenser that combines a sleek iPhone case with an onboard application to track, dispense, and record medication usage according to personalized schedules. Founded in 2013, Remind Technologies aims to enhance disease management by providing tools that encourage adherence to medication regimens, including tracking features and patient incentives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.